Healthcare, ranked by moat.
440 Healthcare companies are scored nightly from primary SEC filings, each 0–100 on pricing power, returns on capital, balance-sheet safety, and capital discipline, via the public methodology. Cross-sector views: the Top 100, the Screener, and the A–Z directory.
- Companies scored
- 440
- Median Moat Score
- 41
- Wide moats
- 30
- Quality on sale
- 5
Widest moats in Healthcare
Quality on sale in Healthcare
- SIGA Technologies, Inc. 63% below value
- USANA HEALTH SCIENCES, INC. 44% below value
- INNOVIVA, INC. 34% below value
- PACIFIC HEALTH CARE ORGANIZATION, INC. 33% below value
- HARMONY BIOSCIENCES HOLDINGS, INC. 25% below value
All 440 scored Healthcare companies
| Watchlist | # | Company | Ticker | Mkt cap | Moat Score | Moat | Margin of safety |
|---|---|---|---|---|---|---|---|
| 1 | ALIGN TECHNOLOGY, INC. | ALGN | $12.6B | 100 | Wide moat | 152% above value | |
| 2 | IDEXX LABORATORIES INC /DE | IDXX | $45.2B | 98 | Wide moat | 197% above value | |
| 3 | CORCEPT THERAPEUTICS INC | CORT | $9.6B | 97 | Wide moat | 706% above value | |
| 4 | REGENERON PHARMACEUTICALS, INC. | REGN | — | 96 | Wide moat | No price data | |
| 5 | Lifevantage Corp | LFVN | $77.1M | 95 | Wide moat | 43% above value | |
| 6 | GARMIN LTD | GRMN | $48.1B | 95 | Wide moat | 144% above value | |
| 7 | INNOVIVA, INC. | INVA | $1.6B | 94 | Wide moat | 34% below value | |
| 8 | UTAH MEDICAL PRODUCTS INC | UTMD | $222.4M | 93 | Wide moat | 41% above value | |
| 9 | TERADYNE, INC. | TER | $50.3B | 91 | Wide moat | 717% above value | |
| 10 | ResMed Inc. | RMD | $29.1B | 90 | Wide moat | 72% above value | |
| 11 | IRADIMED CORPORATION | IRMD | $1.2B | 90 | Wide moat | 301% above value | |
| 12 | Intuitive Surgical, Inc. | ISRG | $122.7B | 90 | Wide moat | 463% above value | |
| 13 | Waters Corporation | WAT | $22.0B | 89 | Wide moat | 146% above value | |
| 14 | SIGA Technologies, Inc. | SIGA | $246.3M | 89 | Wide moat | 63% below value | |
| 15 | EDWARDS LIFESCIENCES CORPORATION | EW | $49.8B | 87 | Wide moat | 198% above value | |
| 16 | EXELIXIS, INC. | EXEL | $14.7B | 85 | Wide moat | 253% above value | |
| 17 | UNITED THERAPEUTICS Corp | UTHR | $23.4B | 85 | Wide moat | 32% above value | |
| 18 | PACIFIC HEALTH CARE ORGANIZATION, INC. | PFHO | $11.0M | 85 | Wide moat | 33% below value | |
| 19 | NATURES SUNSHINE PRODUCTS INC | NATR | $357.7M | 84 | Wide moat | 96% above value | |
| 20 | AGILENT TECHNOLOGIES, INC. | A | $37.2B | 84 | Wide moat | 160% above value | |
| 21 | HARMONY BIOSCIENCES HOLDINGS, INC. | HRMY | $1.9B | 83 | Wide moat | 25% below value | |
| 22 | BADGER METER, INC. | BMI | $5.6B | 82 | Wide moat | 284% above value | |
| 23 | USANA HEALTH SCIENCES, INC. | USNA | $398.9M | 82 | Wide moat | 44% below value | |
| 24 | CATALYST PHARMACEUTICALS, INC. | CPRX | $3.9B | 81 | Wide moat | 158% above value | |
| 25 | Viemed Healthcare, Inc. | VMD | $461.9M | 81 | Wide moat | 306% above value | |
| 26 | WEST PHARMACEUTICAL SERVICES, INC. | WST | $25.8B | 81 | Wide moat | 296% above value | |
| 27 | VERTEX PHARMACEUTICALS INC / MA | VRTX | $123.4B | 81 | Wide moat | 106% above value | |
| 28 | KEYSIGHT TECHNOLOGIES, INC. | KEYS | — | 81 | Wide moat | No price data | |
| 29 | Electromed, Inc. | ELMD | $351.5M | 81 | Wide moat | 841% above value | |
| 30 | MIMEDX GROUP, INC. | MDXG | $636.8M | 80 | Wide moat | 35% above value | |
| 31 | DEXCOM, INC. | DXCM | $29.5B | 78 | Narrow moat | 203% above value | |
| 32 | CHAMPIONS ONCOLOGY, INC. | CSBR | $84.5M | 77 | Narrow moat | 1196% above value | |
| 33 | LEMAITRE VASCULAR, INC. | LMAT | $2.3B | 77 | Narrow moat | 289% above value | |
| 34 | Cognex Corporation | CGNX | $10.7B | 77 | Narrow moat | 811% above value | |
| 35 | GLOBUS MEDICAL, INC. | GMED | — | 77 | Narrow moat | No price data | |
| 36 | ABBOTT LABORATORIES | ABT | $174.9B | 77 | Narrow moat | 205% above value | |
| 37 | NORTHROP GRUMMAN CORP /DE/ | NOC | $74.1B | 77 | Narrow moat | 59% above value | |
| 38 | Rockwell Automation, Inc. | ROK | $51.9B | 76 | Narrow moat | 347% above value | |
| 39 | Illumina, Inc. | ILMN | $28.6B | 76 | Narrow moat | No price data | |
| 40 | GILEAD SCIENCES, INC. | GILD | $166.6B | 75 | Narrow moat | 82% above value | |
| 41 | CODA OCTOPUS GROUP, INC. | CODA | $112.9M | 74 | Narrow moat | 146% above value | |
| 42 | LANTHEUS HOLDINGS, INC. | LNTH | $6.9B | 74 | Narrow moat | 168% above value | |
| 43 | MANNATECH INC | MTEX | $8.1M | 74 | Narrow moat | No price data | |
| 44 | Elite Pharmaceuticals, Inc. | ELTP | $418.2M | 73 | Narrow moat | 142% above value | |
| 45 | TRANE TECHNOLOGIES PLC | TT | — | 73 | Narrow moat | No price data | |
| 46 | AMETEK, Inc. | AME | $54.3B | 72 | Narrow moat | 99% above value | |
| 47 | TACTILE SYSTEMS TECHNOLOGY INC | TCMD | $644.9M | 72 | Narrow moat | 172% above value | |
| 48 | HALOZYME THERAPEUTICS, INC. | HALO | $9.2B | 72 | Narrow moat | 157% above value | |
| 49 | OPTEX SYSTEMS HOLDINGS, INC. | OPXS | $88.3M | 72 | Narrow moat | 117% above value | |
| 50 | Vontier Corporation | VNT | $4.3B | 72 | Narrow moat | 4% below value | |
| 51 | AUTOSCOPE TECHNOLOGIES CORP | AATC | $29.2M | 71 | Narrow moat | 58% above value | |
| 52 | Amgen Inc. | AMGN | $197.4B | 71 | Narrow moat | 21% above value | |
| 53 | FITLIFE BRANDS, INC. | FTLF | $103.9M | 71 | Narrow moat | 7% above value | |
| 54 | MSA Safety Inc | MSA | $6.7B | 70 | Narrow moat | 101% above value | |
| 55 | NEUROCRINE BIOSCIENCES, INC. | NBIX | $17.1B | 70 | Narrow moat | 329% above value | |
| 56 | IRONWOOD PHARMACEUTICALS, INC. | IRWD | $629.4M | 70 | Narrow moat | 126% above value | |
| 57 | ONTO INNOVATION INC. | ONTO | $13.9B | 69 | Narrow moat | 861% above value | |
| 58 | 3M COMPANY | MMM | $84.8B | 68 | Narrow moat | 75% above value | |
| 59 | STRYKER CORP | SYK | — | 68 | Narrow moat | No price data | |
| 60 | PRO-DEX, INC. | PDEX | $187.1M | 68 | Narrow moat | 68% above value | |
| 61 | MOVADO GROUP, INC. | MOV | $874.0M | 67 | Narrow moat | 84% above value | |
| 62 | JRSIS HEALTH CARE CORPORATION | JRSS | $1.3M | 66 | Narrow moat | 87% below value | |
| 63 | ENSIGN GROUP, INC | ENSG | $9.9B | 65 | Narrow moat | 146% above value | |
| 64 | Prestige Consumer Healthcare Inc. | PBH | $2.4B | 65 | Narrow moat | 7% below value | |
| 65 | SUPERNUS PHARMACEUTICALS, INC. | SUPN | $2.8B | 65 | Narrow moat | 190% above value | |
| 66 | LIGAND PHARMACEUTICALS INCORPORATED | LGND | $6.0B | 64 | Narrow moat | 291% above value | |
| 67 | U S PHYSICAL THERAPY INC /NV | USPH | — | 64 | Narrow moat | No price data | |
| 68 | ZIMMER BIOMET HOLDINGS, INC. | ZBH | $17.8B | 64 | Narrow moat | 37% below value | |
| 69 | CHEMED CORPORATION | CHE | $7.0B | 63 | Narrow moat | 135% above value | |
| 70 | Gyre Therapeutics, Inc. | GYRE | $552.4M | 63 | Narrow moat | 1053% above value | |
| 71 | BIO-TECHNE Corp | TECH | $11.2B | 62 | Narrow moat | 364% above value | |
| 72 | QUEST DIAGNOSTICS INC | DGX | $23.1B | 62 | Narrow moat | 113% above value | |
| 73 | Alpha Pro Tech, Ltd. | APT | $52.3M | 61 | Narrow moat | 20% above value | |
| 74 | COLLEGIUM PHARMACEUTICAL, INC | COLL | $1.1B | 61 | Narrow moat | 68% above value | |
| 75 | National Vision Holdings, Inc. | EYE | $1.6B | 61 | Narrow moat | 252% above value | |
| 76 | AbbVie Inc. | ABBV | $450.0B | 59 | Shallow moat | 891% above value | |
| 77 | Leonardo DRS, Inc. | DRS | $11.7B | 59 | Shallow moat | 198% above value | |
| 78 | CADRE HOLDINGS, INC. | CDRE | $1.2B | 59 | Shallow moat | 45% above value | |
| 79 | BOSTON SCIENTIFIC CORP | BSX | — | 59 | Shallow moat | No price data | |
| 80 | Penumbra, Inc | PEN | $12.5B | 59 | Shallow moat | 4096% above value | |
| 81 | STERIS plc | STE | $21.3B | 59 | Shallow moat | 103% above value | |
| 82 | Synergy CHC Corp. | SNYR | $2.1M | 58 | Shallow moat | No price data | |
| 83 | ANI Pharmaceuticals, Inc. | ANIP | $1.8B | 58 | Shallow moat | 200% above value | |
| 84 | Progyny, Inc. | PGNY | $2.7B | 58 | Shallow moat | 309% above value | |
| 85 | DELCATH SYSTEMS, INC. | DCTH | $444.4M | 57 | Shallow moat | No price data | |
| 86 | ORGANOGENESIS HOLDINGS INC. | ORGO | $332.6M | 57 | Shallow moat | 93% above value | |
| 87 | TRIMBLE INC. | TRMB | $12.4B | 57 | Shallow moat | 20% above value | |
| 88 | THERMO FISHER SCIENTIFIC INC. | TMO | $197.8B | 57 | Shallow moat | 261% above value | |
| 89 | BIOVENTUS INC. | BVS | $831.1M | 56 | Shallow moat | 272% above value | |
| 90 | IMAX Corporation | IMAX | $2.1B | 56 | Shallow moat | 49% above value | |
| 91 | ACADIA PHARMACEUTICALS INC | ACAD | $4.4B | 56 | Shallow moat | No price data | |
| 92 | TELEDYNE TECHNOLOGIES INC | TDY | $29.4B | 56 | Shallow moat | 56% above value | |
| 93 | BRUKER CORPORATION | BRKR | $8.9B | 56 | Shallow moat | 188% above value | |
| 94 | HIMS & HERS HEALTH, INC. | HIMS | $8.5B | 56 | Shallow moat | No price data | |
| 95 | PROTALIX BIOTHERAPEUTICS, INC. | PLX | $191.4M | 56 | Shallow moat | No price data | |
| 96 | RIGEL PHARMACEUTICALS INC | RIGL | $742.3M | 55 | Shallow moat | No price data | |
| 97 | Kiniksa Pharmaceuticals International, plc | KNSA | $5.1B | 55 | Shallow moat | 2690% above value | |
| 98 | PTC Therapeutics, Inc. | PTCT | $6.4B | 55 | Shallow moat | No price data | |
| 99 | Fortive Corp | FTV | $19.4B | 55 | Shallow moat | 55% above value | |
| 100 | UFP Technologies, Inc. | UFPT | $1.9B | 55 | Shallow moat | 126% above value | |
| 101 | Niagen Bioscience, Inc. | NAGE | $261.5M | 55 | Shallow moat | No price data | |
| 102 | InTest Corporation | INTT | $167.8M | 54 | Shallow moat | 60% above value | |
| 103 | VERACYTE, INC. | VCYT | $4.7B | 54 | Shallow moat | No price data | |
| 104 | Alkermes plc. | ALKS | $8.7B | 53 | Shallow moat | 101% above value | |
| 105 | Anika Therapeutics, Inc. | ANIK | $211.8M | 53 | Shallow moat | No price data | |
| 106 | Maravai LifeSciences Holdings, Inc. | MRVI | $1.0B | 52 | Shallow moat | No price data | |
| 107 | REPLIGEN CORP | RGEN | $8.3B | 52 | Shallow moat | 617% above value | |
| 108 | Cardiff Lexington Corporation | CDIX | $12.3M | 51 | Shallow moat | No price data | |
| 109 | PUMA BIOTECHNOLOGY, INC. | PBYI | $430.0M | 51 | Shallow moat | 17% above value | |
| 110 | CUMBERLAND PHARMACEUTICALS INC | CPIX | $102.3M | 50 | Shallow moat | No price data | |
| 111 | INSULET CORPORATION | PODD | $11.5B | 50 | Shallow moat | 211% above value | |
| 112 | Aurinia Pharmaceuticals Inc. | AUPH | $2.1B | 50 | Shallow moat | No price data | |
| 113 | AKEBIA THERAPEUTICS, INC. | AKBA | $355.7M | 50 | Shallow moat | No price data | |
| 114 | Electro-Sensors, Inc. | ELSE | $26.8M | 50 | Shallow moat | 631% above value | |
| 115 | Orchestra BioMed Holdings, Inc. | OBIO | $209.9M | 50 | Shallow moat | No price data | |
| 116 | The Cooper Companies, Inc. | COO | $14.0B | 50 | Shallow moat | 222% above value | |
| 117 | STAAR SURGICAL CO | STAA | $1.3B | 50 | Shallow moat | 3621% above value | |
| 118 | BIORESTORATIVE THERAPIES, INC. | BRTX | $3.0M | 50 | Shallow moat | No price data | |
| 119 | INTERPACE BIOSCIENCES, INC. | IDXG | $6.3M | 49 | Shallow moat | 77% below value | |
| 120 | Bio-Rad Laboratories, Inc. | BIO | $8.3B | 49 | Shallow moat | No price data | |
| 121 | VASO CORPORATION | VASO | $34.5M | 49 | Shallow moat | 35% below value | |
| 122 | BioMarin Pharmaceutical Inc | BMRN | $11.5B | 49 | Shallow moat | 488% above value | |
| 123 | Whitehawk Therapeutics, Inc. | WHWK | $183.4M | 49 | Shallow moat | No price data | |
| 124 | Inspire Medical Systems, Inc. | INSP | $1.4B | 49 | Shallow moat | No price data | |
| 125 | Medtronic plc | MDT | $106.5B | 49 | Shallow moat | 69% above value | |
| 126 | ENVISTA HOLDINGS CORPORATION | NVST | $4.4B | 49 | Shallow moat | 235% above value | |
| 127 | MYOMO, INC. | MYO | $36.6M | 49 | Shallow moat | No price data | |
| 128 | Vir Biotechnology, Inc. | VIR | $1.3B | 49 | Shallow moat | No price data | |
| 129 | Celldex Therapeutics, Inc. | CLDX | $2.4B | 48 | Shallow moat | No price data | |
| 130 | NEPHROS, INC. | NEPH | $40.2M | 48 | Shallow moat | No price data | |
| 131 | Phibro Animal Health Corporation | PAHC | — | 48 | Shallow moat | No price data | |
| 132 | BEONE MEDICINES LTD. | ONC | $449.6B | 48 | Shallow moat | No price data | |
| 133 | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | TEVA | $36.8B | 48 | Shallow moat | 2909% above value | |
| 134 | ROPER TECHNOLOGIES INC | ROP | $38.7B | 48 | Shallow moat | 40% above value | |
| 135 | TG THERAPEUTICS, INC. | TGTX | $8.5B | 48 | Shallow moat | 5850% above value | |
| 136 | InfuSystem Holdings, Inc. | INFU | $180.3M | 48 | Shallow moat | 27% below value | |
| 137 | TRULIEVE CANNABIS CORP. | TRLV | $1.7B | 48 | Shallow moat | No price data | |
| 138 | TALKSPACE, INC. | TALK | $868.6M | 48 | Shallow moat | No price data | |
| 139 | KORU MEDICAL SYSTEMS, INC. | KRMD | $190.6M | 47 | Shallow moat | No price data | |
| 140 | Sarepta Therapeutics, Inc. | SRPT | $1.8B | 47 | Shallow moat | No price data | |
| 141 | LogicMark, Inc. | LGMK | $648167 | 47 | Shallow moat | No price data | |
| 142 | LivaNova PLC | LIVN | $4.4B | 47 | Shallow moat | No price data | |
| 143 | Danaher Corporation | DHR | $144.1B | 47 | Shallow moat | 134% above value | |
| 144 | MIND TECHNOLOGY, INC | MIND | $47.0M | 47 | Shallow moat | 341% above value | |
| 145 | BIOCRYST PHARMACEUTICALS, INC. | BCRX | $2.0B | 47 | Shallow moat | No price data | |
| 146 | AtriCure, Inc. | ATRC | $1.7B | 47 | Shallow moat | No price data | |
| 147 | CASTLE BIOSCIENCES, INC. | CSTL | $717.2M | 47 | Shallow moat | No price data | |
| 148 | uniQure N.V. | QURE | $2.5B | 47 | Shallow moat | No price data | |
| 149 | Neogen Corporation | NEOG | $2.2B | 47 | Shallow moat | No price data | |
| 150 | LFTD PARTNERS INC. | LIFD | $2.8M | 47 | Shallow moat | 88% below value | |
| 151 | Petros Pharmaceuticals, Inc. | PTPI | $173366 | 46 | Shallow moat | No price data | |
| 152 | Data I/O Corporation | DAIO | $31.5M | 46 | Shallow moat | No price data | |
| 153 | MYRIAD GENETICS, INC. | MYGN | $577.8M | 46 | Shallow moat | No price data | |
| 154 | X4 Pharmaceuticals, Inc. | XFOR | $347.3M | 46 | Shallow moat | No price data | |
| 155 | COMMUNITY HEALTH SYSTEMS, INC. | CYH | $457.5M | 46 | Shallow moat | 85% below value | |
| 156 | Itron, Inc. | ITRI | $3.9B | 46 | Shallow moat | 176% above value | |
| 157 | Sensus Healthcare, Inc. | SRTS | $49.7M | 46 | Shallow moat | 3% below value | |
| 158 | BioLife Solutions, Inc. | BLFS | $1.4B | 46 | Shallow moat | No price data | |
| 159 | IMMUNITYBIO, INC. | IBRX | $7.8B | 46 | Shallow moat | No price data | |
| 160 | Ultragenyx Pharmaceutical Inc. | RARE | $2.8B | 46 | Shallow moat | No price data | |
| 161 | INTELLIA THERAPEUTICS, INC. | NTLA | $1.3B | 46 | Shallow moat | No price data | |
| 162 | Stereotaxis, Inc. | STXS | — | 46 | Shallow moat | No price data | |
| 163 | Xtant Medical Holdings, Inc. | XTNT | $63.0M | 46 | Shallow moat | No price data | |
| 164 | Zomedica Corp. | ZOMDF | — | 46 | Shallow moat | No price data | |
| 165 | HAEMONETICS CORPORATION | HAE | $3.5B | 46 | Shallow moat | 11% above value | |
| 166 | Inogen Inc | INGN | $178.9M | 46 | Shallow moat | No price data | |
| 167 | MERIT MEDICAL SYSTEMS INC | MMSI | $4.4B | 45 | Shallow moat | 63% above value | |
| 168 | Schrodinger, Inc. | SDGR | — | 45 | Shallow moat | No price data | |
| 169 | Addus HomeCare Corp | ADUS | $2.1B | 45 | Shallow moat | 75% above value | |
| 170 | ZAI LAB LIMITED | ZLAB | $22.3B | 45 | Shallow moat | No price data | |
| 171 | DENTSPLY SIRONA Inc. | XRAY | $2.8B | 45 | Shallow moat | No price data | |
| 172 | VERICEL CORPORATION | VCEL | $2.4B | 45 | Shallow moat | No price data | |
| 173 | AYTU BIOPHARMA, INC | AYTU | $19.3M | 45 | Shallow moat | No price data | |
| 174 | SI-BONE, INC. | SIBN | $758.6M | 45 | Shallow moat | No price data | |
| 175 | Lexicon Pharmaceuticals, Inc. | LXRX | $874.4M | 45 | Shallow moat | No price data | |
| 176 | Agios Pharmaceuticals, Inc. | AGIO | $2.3B | 45 | Shallow moat | No price data | |
| 177 | CVRx, Inc. | CVRX | $129.2M | 45 | Shallow moat | No price data | |
| 178 | Fortress Biotech, Inc. | FBIO | $105.4M | 45 | Shallow moat | No price data | |
| 179 | PULMONX CORPORATION | LUNG | $58.3M | 44 | Shallow moat | No price data | |
| 180 | Clearside Biomedical, Inc. | CLSDQ | $19.1M | 44 | Shallow moat | No price data | |
| 181 | TransMedics Group, Inc. | TMDX | $2.5B | 44 | Shallow moat | No price data | |
| 182 | L3HARRIS TECHNOLOGIES, INC. | LHX | $52.7B | 44 | Shallow moat | 99% above value | |
| 183 | ORTHOFIX MEDICAL INC. | OFIX | $461.3M | 44 | Shallow moat | No price data | |
| 184 | Alphatec Holdings, Inc. | ATEC | $1.3B | 44 | Shallow moat | No price data | |
| 185 | Warby Parker Inc. | WRBY | $3.3B | 44 | Shallow moat | No price data | |
| 186 | Crinetics Pharmaceuticals, Inc. | CRNX | $8.0B | 44 | Shallow moat | No price data | |
| 187 | INTEGRA LIFESCIENCES HOLDINGS CORP | IART | $1.5B | 44 | Shallow moat | 15314% above value | |
| 188 | SANARA MEDTECH INC. | SMTI | $223.7M | 44 | Shallow moat | No price data | |
| 189 | SIGHT SCIENCES, INC. | SGHT | $269.1M | 44 | Shallow moat | No price data | |
| 190 | RHYTHM PHARMACEUTICALS, INC. | RYTM | $7.2B | 44 | Shallow moat | No price data | |
| 191 | PROCYON CORPORATION | PCYN | $1.4M | 44 | Shallow moat | No price data | |
| 192 | Femasys Inc. | FEMY | $179.4M | 44 | Shallow moat | No price data | |
| 193 | 10x Genomics, Inc. | TXG | $5.6B | 44 | Shallow moat | No price data | |
| 194 | TELADOC HEALTH, INC. | TDOC | $1.7B | 44 | Shallow moat | No price data | |
| 195 | MKS INC | MKSI | $21.8B | 44 | Shallow moat | 368% above value | |
| 196 | Bausch Health Companies Inc. | BHC | $1.8B | 43 | Shallow moat | 89% below value | |
| 197 | XBIOTECH INC. | XBIT | $69.2M | 43 | Shallow moat | No price data | |
| 198 | Verrica Pharmaceuticals Inc. | VRCA | $96.0M | 43 | Shallow moat | No price data | |
| 199 | CYTEK BIOSCIENCES, INC. | CTKB | $593.9M | 43 | Shallow moat | No price data | |
| 200 | CAREDX, INC. | CDNA | $2.0B | 43 | Shallow moat | No price data | |
| 201 | Lineage Cell Therapeutics, Inc. | LCTX | $282.0M | 43 | Shallow moat | No price data | |
| 202 | EMERGENT BIOSOLUTIONS INC. | EBS | $397.5M | 43 | Shallow moat | No price data | |
| 203 | Pyxis Oncology, Inc. | PYXS | $147.9M | 43 | Shallow moat | No price data | |
| 204 | NEKTAR THERAPEUTICS | NKTR | $1.4B | 43 | Shallow moat | No price data | |
| 205 | STRATA SKIN SCIENCES, INC. | SSKN | $529938 | 43 | Shallow moat | No price data | |
| 206 | Avalo Therapeutics, Inc. | AVTX | $358.6M | 43 | Shallow moat | No price data | |
| 207 | Kewaunee Scientific Corporation | KEQU | $109.2M | 43 | Shallow moat | 18% below value | |
| 208 | Escalon Medical Corp. | ESMC | $1.5M | 43 | Shallow moat | 101% above value | |
| 209 | VERU INC. | VERU | $34.9M | 43 | Shallow moat | No price data | |
| 210 | IONIS PHARMACEUTICALS, INC. | IONS | $8.9B | 43 | Shallow moat | No price data | |
| 211 | Exagen Inc. | XGN | $100.6M | 43 | Shallow moat | No price data | |
| 212 | AngioDynamics, Inc. | ANGO | $563.4M | 43 | Shallow moat | No price data | |
| 213 | Milestone Scientific Inc. | MLSS | $34.0M | 42 | Shallow moat | No price data | |
| 214 | REVVITY, INC | RVTY | $12.4B | 42 | Shallow moat | 22% above value | |
| 215 | Lite Strategy, Inc. | LITS | $6.6M | 42 | Shallow moat | No price data | |
| 216 | 908 DEVICES INC. | MASS | $267.0M | 42 | Shallow moat | No price data | |
| 217 | TELEFLEX INCORPORATED | TFX | $5.9B | 42 | Shallow moat | 17% above value | |
| 218 | ORASURE TECHNOLOGIES, INC | OSUR | $272.4M | 42 | Shallow moat | No price data | |
| 219 | VIVOSIM LABS, INC. | VIVS | $1.7M | 42 | Shallow moat | No price data | |
| 220 | Elutia Inc. | ELUT | — | 42 | Shallow moat | No price data | |
| 221 | AVANOS MEDICAL, INC. | AVNS | $1.2B | 41 | Shallow moat | No price data | |
| 222 | Immuneering Corporation | IMRX | $204.2M | 41 | Shallow moat | No price data | |
| 223 | NEURONETICS, INC. | STIM | $111.8M | 41 | Shallow moat | No price data | |
| 224 | ALLIENT INC | ALNT | $1.5B | 41 | Shallow moat | 181% above value | |
| 225 | Stablecoin Development Corporation | SDEV | $32.5M | 41 | Shallow moat | No price data | |
| 226 | Vivos Therapeutics, Inc. | VVOS | $3.9M | 41 | Shallow moat | No price data | |
| 227 | Nuo Therapeutics, Inc. | AURX | $48.2M | 41 | Shallow moat | No price data | |
| 228 | LEXARIA BIOSCIENCE CORP. | LEXX | $12.4M | 41 | Shallow moat | No price data | |
| 229 | Zevra Therapeutics, Inc. | ZVRA | $726.0M | 41 | Shallow moat | No price data | |
| 230 | electroCore, Inc. | ECOR | $47.1M | 41 | Shallow moat | No price data | |
| 231 | VYNE THERAPEUTICS INC. | VYNE | $25.4M | 41 | Shallow moat | No price data | |
| 232 | Lifeward Ltd. | LFWD | $12.1M | 41 | Shallow moat | No price data | |
| 233 | Decoy Therapeutics Inc. | DCOY | — | 41 | Shallow moat | No price data | |
| 234 | Longeveron Inc. | LGVN | $10.9B | 41 | Shallow moat | No price data | |
| 235 | Nexentis Technologies Inc. | NXTS | $6.3M | 41 | Shallow moat | No price data | |
| 236 | Mirion Technologies, Inc. | MIR | — | 41 | Shallow moat | No price data | |
| 237 | CO-DIAGNOSTICS, INC. | CODX | $74 | 40 | Shallow moat | No price data | |
| 238 | INSMED INCORPORATED | INSM | $23.2B | 40 | Shallow moat | No price data | |
| 239 | MACROGENICS, INC. | MGNX | $284.3M | 40 | Shallow moat | No price data | |
| 240 | OMEROS CORPORATION | OMER | $694.5M | 40 | Shallow moat | No price data | |
| 241 | OrthoPediatrics Corp | KIDS | $482.2M | 40 | Shallow moat | No price data | |
| 242 | TRAVERE THERAPEUTICS, INC. | TVTX | $5.2B | 40 | Shallow moat | No price data | |
| 243 | NEUROPACE, INC. | NPCE | $539.9M | 40 | Shallow moat | No price data | |
| 244 | Treace Medical Concepts, Inc. | TMCI | — | 40 | Shallow moat | No price data | |
| 245 | PACIRA BIOSCIENCES, INC. | PCRX | $1.1B | 40 | Shallow moat | 24% below value | |
| 246 | AGENUS INC | AGEN | $177.0M | 40 | Shallow moat | No price data | |
| 247 | PRECIGEN, INC. | PGEN | $1.8B | 40 | Shallow moat | No price data | |
| 248 | GUARDANT HEALTH, INC. | GH | $20.4B | 40 | Shallow moat | No price data | |
| 249 | QHSLab, Inc. | USAQ | $6.6M | 40 | No moat | No price data | |
| 250 | NATURAL ALTERNATIVES INTERNATIONAL INC | NAII | $13.7M | 40 | No moat | 51% below value | |
| 251 | CAPFORCE INC. | CFOR | $203.0M | 40 | No moat | No price data | |
| 252 | iRhythm Holdings, Inc. | IRTC | $3.6B | 40 | No moat | No price data | |
| 253 | Moderna, Inc. | MRNA | $24.4B | 40 | No moat | No price data | |
| 254 | AXOGEN, INC. | AXGN | $1.9B | 40 | No moat | No price data | |
| 255 | Journey Medical Corp | DERM | $175.4M | 40 | No moat | No price data | |
| 256 | APYX MEDICAL CORPORATION | APYX | $178.8M | 40 | No moat | No price data | |
| 257 | ARCUTIS BIOTHERAPEUTICS, INC. | ARQT | $3.5B | 39 | No moat | No price data | |
| 258 | ARDELYX, INC. | ARDX | $1.3B | 39 | No moat | No price data | |
| 259 | LABCORP HOLDINGS INC. | LH | $23.3B | 39 | No moat | 87% above value | |
| 260 | CYTOSORBENTS CORPORATION | CTSO | $22.6M | 39 | No moat | No price data | |
| 261 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | $35.4B | 39 | No moat | No price data | |
| 262 | Nuwellis, Inc. | NUWE | $4.8M | 39 | No moat | No price data | |
| 263 | TRANSCAT INC | TRNS | $820.5M | 39 | No moat | 228% above value | |
| 264 | STANDARD BIOTOOLS INC. | LAB | $351.6M | 39 | No moat | No price data | |
| 265 | CLEARPOINT NEURO, INC. | CLPT | $444.9M | 39 | No moat | No price data | |
| 266 | Silence Therapeutics plc | SLN | $1.5B | 38 | No moat | No price data | |
| 267 | Establishment Labs Holdings Inc. | ESTA | $2.7B | 38 | No moat | No price data | |
| 268 | QUANTUM-SI INCORPORATED | QSI | $162.6M | 38 | No moat | No price data | |
| 269 | INTEGRATED BIOPHARMA INC | INBP | $5.0M | 38 | No moat | 52% below value | |
| 270 | ENDRA Life Sciences Inc. | NDRA | $5.9M | 38 | No moat | No price data | |
| 271 | INTERNATIONAL STEM CELL CORPORATION | ISCO | $1.4M | 38 | No moat | No price data | |
| 272 | EVOLUS, INC. | EOLS | $372.5M | 38 | No moat | No price data | |
| 273 | Amphastar Pharmaceuticals, Inc. | AMPH | $901.3M | 38 | No moat | 16% below value | |
| 274 | ADAPTIVE BIOTECHNOLOGIES CORPORATION | ADPT | $3.5B | 38 | No moat | No price data | |
| 275 | SCIENTIFIC INDUSTRIES, INC. | SCND | $8.0M | 37 | No moat | No price data | |
| 276 | HARVARD BIOSCIENCE, INC. | HBIO | $278.6M | 37 | No moat | No price data | |
| 277 | BAXTER INTERNATIONAL INC | BAX | $11.6B | 37 | No moat | No price data | |
| 278 | ORAMED PHARMACEUTICALS INC. | ORMP | $158.7M | 37 | No moat | No price data | |
| 279 | ENCISION, INC. | ECIA | $536960 | 37 | No moat | No price data | |
| 280 | THERAVANCE BIOPHARMA, INC. | TBPH | $864.6M | 37 | No moat | No price data | |
| 281 | AEHR TEST SYSTEMS | AEHR | $2.4B | 37 | No moat | 2206% above value | |
| 282 | GLAUKOS Corp | GKOS | $9.0B | 37 | No moat | No price data | |
| 283 | Scienture Holdings, Inc. | SCNX | $16.8M | 37 | No moat | No price data | |
| 284 | LIQUIDIA CORPORATION | LQDA | $7.0B | 37 | No moat | No price data | |
| 285 | NovoCure Limited | NVCR | $1.8B | 36 | No moat | No price data | |
| 286 | Fossil Group, Inc. | FOSL | $241.6M | 36 | No moat | No price data | |
| 287 | enVVeno Medical Corporation | NVNO | $7.1M | 36 | No moat | No price data | |
| 288 | QUANTERIX CORPORATION | QTRX | $180.7M | 36 | No moat | No price data | |
| 289 | SONOMA PHARMACEUTICALS, INC. | SNOA | $2.2M | 36 | No moat | No price data | |
| 290 | REGENXBIO Inc. | RGNX | $503.3M | 36 | No moat | No price data | |
| 291 | Tandem Diabetes Care, Inc. | TNDM | $1.2B | 36 | No moat | No price data | |
| 292 | TELA Bio, Inc. | TELA | $32.6M | 36 | No moat | No price data | |
| 293 | STREAMEX CORP. | STEX | $39.0M | 36 | No moat | No price data | |
| 294 | BECTON DICKINSON & CO | BDX | $45.1B | 36 | No moat | Around fair value | |
| 295 | CERUS CORPORATION | CERS | $601.4M | 36 | No moat | No price data | |
| 296 | RADNOSTIX INC. | INIS | $37.1M | 36 | No moat | No price data | |
| 297 | LIFEMD, INC. | LFMD | $193.6M | 35 | No moat | No price data | |
| 298 | ABVC BioPharma, Inc. | ABVC | $31.3M | 35 | No moat | No price data | |
| 299 | INVO FERTILITY, INC. | IVF | $496461 | 35 | No moat | No price data | |
| 300 | iBio, Inc. | IBIO | $26.7M | 35 | No moat | No price data | |
| 301 | PetVivo Holdings, Inc. | PETV | $27.6M | 35 | No moat | No price data | |
| 302 | Jaguar Health, Inc. | JAGX | — | 35 | No moat | No price data | |
| 303 | HYPERION DEFI, INC. | HYPD | $23.8M | 35 | No moat | No price data | |
| 304 | Serina Therapeutics, Inc. | SER | $22.9M | 35 | No moat | No price data | |
| 305 | ARTIVION, INC. | AORT | $1.2B | 35 | No moat | No price data | |
| 306 | ADM TRONICS UNLIMITED, INC. | ADMT | $2.2M | 35 | No moat | No price data | |
| 307 | PLURI INC. | PLUR | $14.7M | 35 | No moat | No price data | |
| 308 | AVITA MEDICAL, INC. | RCEL | $155.9M | 35 | No moat | No price data | |
| 309 | INMED PHARMACEUTICALS INC. | INM | $3.0M | 35 | No moat | No price data | |
| 310 | KYNTRA BIO, INC. | KYNB | $29.3M | 35 | No moat | No price data | |
| 311 | TherapeuticsMD, Inc. | TXMD | $23.8M | 34 | No moat | No price data | |
| 312 | LENSAR, Inc. | LNSR | $69.6M | 34 | No moat | No price data | |
| 313 | NATERA, INC. | NTRA | $37.9B | 34 | No moat | No price data | |
| 314 | SIGYN THERAPEUTICS, INC. | SIGY | $40134 | 34 | No moat | No price data | |
| 315 | MESA LABORATORIES, INC. | MLAB | $541.1M | 34 | No moat | 1307% above value | |
| 316 | AMARIN CORP PLC\UK | AMRN | $5.8B | 34 | No moat | No price data | |
| 317 | ADMA BIOLOGICS, INC. | ADMA | $2.1B | 34 | No moat | No price data | |
| 318 | VIREO GROWTH INC. | VREOF | $7.2B | 34 | No moat | No price data | |
| 319 | APPLIED ENERGETICS, INC. | AERG | $273.2M | 34 | No moat | No price data | |
| 320 | Seer, Inc. | SEER | — | 34 | No moat | No price data | |
| 321 | Sintx Technologies, Inc. | SINT | $6.3M | 34 | No moat | No price data | |
| 322 | Aclaris Therapeutics, Inc. | ACRS | $684.4M | 33 | No moat | No price data | |
| 323 | MARIMED INC. | MRMD | $26.1M | 33 | No moat | No price data | |
| 324 | Surgery Partners, Inc. | SGRY | $2.1B | 33 | No moat | No price data | |
| 325 | Fulgent Genetics, Inc. | FLGT | $626.6M | 33 | No moat | No price data | |
| 326 | CONMED CORPORATION | CNMD | $1.3B | 33 | No moat | 164% above value | |
| 327 | ENvue Medical, Inc. | FEED | $5 | 33 | No moat | No price data | |
| 328 | HERON THERAPEUTICS, INC. /DE/ | HRTX | $88.6M | 33 | No moat | No price data | |
| 329 | Eton Pharmaceuticals, Inc. | ETON | $1.1B | 33 | No moat | No price data | |
| 330 | PROCEPT BioRobotics Corporation | PRCT | $1.1B | 33 | No moat | No price data | |
| 331 | GeneDx Holdings Corp. | WGS | $1.9B | 33 | No moat | No price data | |
| 332 | Avantor, Inc. | AVTR | $7.5B | 32 | No moat | 19% below value | |
| 333 | PERSPECTIVE THERAPEUTICS, INC. | CATX | $222.3M | 32 | No moat | No price data | |
| 334 | VYOME HOLDINGS, INC. | HIND | $12.7M | 32 | No moat | No price data | |
| 335 | Harrow, Inc. | HROW | $1.7B | 32 | No moat | No price data | |
| 336 | SUNSHINE BIOPHARMA INC. | SBFM | $8.8M | 32 | No moat | No price data | |
| 337 | Cryoport, Inc. | CYRX | $823.0M | 32 | No moat | No price data | |
| 338 | COHU INC | COHU | $2.6B | 32 | No moat | 272% above value | |
| 339 | GOPRO, INC. | GPRO | — | 32 | No moat | No price data | |
| 340 | AMNEAL PHARMACEUTICALS, INC. | AMRX | — | 32 | No moat | No price data | |
| 341 | EMMAUS LIFE SCIENCES, INC. | EMMA | $800146 | 31 | No moat | No price data | |
| 342 | Perrigo Company plc | PRGO | $1.5B | 31 | No moat | 46% above value | |
| 343 | UroGen Pharma Ltd. | URGN | $1.9B | 31 | No moat | No price data | |
| 344 | LIFELOC TECHNOLOGIES, INC. | LCTC | $10.5M | 31 | No moat | No price data | |
| 345 | Quarta-Rad, Inc. | QURT | $7.9M | 31 | No moat | No price data | |
| 346 | IRIDEX CORP | IRIX | $16.2M | 31 | No moat | No price data | |
| 347 | APTEVO THERAPEUTICS INC. | APVO | $4.6M | 30 | No moat | No price data | |
| 348 | RETRACTABLE TECHNOLOGIES INC | RVP | $20.5M | 30 | No moat | No price data | |
| 349 | INTEGER HOLDINGS CORPORATION | ITGR | $3.3B | 30 | No moat | 48% above value | |
| 350 | CV Sciences, Inc. | CVSI | $3.7M | 30 | No moat | No price data | |
| 351 | Lakeland Industries, Inc. | LAKE | $112.1M | 29 | No moat | 439% above value | |
| 352 | Edesa Biotech, Inc. | EDSA | $46.4M | 29 | No moat | No price data | |
| 353 | ImmuCell Corporation | ICCC | $100.6M | 29 | No moat | No price data | |
| 354 | OPKO Health, Inc. | OPK | — | 29 | No moat | No price data | |
| 355 | Enovis CORP | ENOV | $1.5B | 29 | No moat | 126% above value | |
| 356 | InnovAge Holding Corp. | INNV | $1.6B | 29 | No moat | No price data | |
| 357 | China Foods Holdings Ltd. | CFOO | $13.4M | 29 | No moat | No price data | |
| 358 | HURCO COMPANIES, INC. | HURC | $140.1M | 28 | No moat | 75% above value | |
| 359 | Insight Molecular Diagnostics Inc. | IMDX | $136.0M | 28 | No moat | No price data | |
| 360 | CORMEDIX INC. | CRMD | $667.4M | 28 | No moat | No price data | |
| 361 | RxSIGHT, INC. | RXST | $228.9M | 28 | No moat | No price data | |
| 362 | GEOSPACE TECHNOLOGIES CORP | GEOS | $87.2M | 27 | No moat | 122% above value | |
| 363 | Intelligent Bio Solutions Inc. | INBS | $15.5M | 27 | No moat | No price data | |
| 364 | SENSATA TECHNOLOGIES HOLDING PLC | ST | — | 27 | No moat | No price data | |
| 365 | BESPOKE EXTRACTS, INC. | BSPK | $1.1M | 27 | No moat | No price data | |
| 366 | US NUCLEAR CORP. | UCLE | $2.3M | 27 | No moat | No price data | |
| 367 | Cyanotech Corp | CYAN | $3.8M | 27 | No moat | No price data | |
| 368 | Q/C Technologies, Inc. | QCLS | $26.5M | 27 | No moat | No price data | |
| 369 | OPTION CARE HEALTH, INC. | OPCH | $3.4B | 26 | No moat | 19% below value | |
| 370 | Twist Bioscience Corporation | TWST | $5.7B | 26 | No moat | No price data | |
| 371 | Bionano Genomics, Inc. | BNGO | $12.4M | 26 | No moat | No price data | |
| 372 | Tonix Pharmaceuticals Holding Corp. | TNXP | $6.9B | 26 | No moat | No price data | |
| 373 | PRECISION OPTICS CORPORATION, INC. | POCI | $33.5M | 25 | No moat | No price data | |
| 374 | PRECIPIO, INC. | PRPO | $43.9M | 25 | No moat | No price data | |
| 375 | Viatris Inc | VTRS | — | 25 | No moat | No price data | |
| 376 | ICU MEDICAL INC/DE | ICUI | $3.9B | 25 | No moat | 209% above value | |
| 377 | IOVANCE BIOTHERAPEUTICS, INC. | IOVA | $2.1B | 25 | No moat | No price data | |
| 378 | KYMERA THERAPEUTICS, INC. | KYMR | $9.4B | 25 | No moat | No price data | |
| 379 | Aveanna Healthcare Holdings Inc. | AVAH | $2.0B | 24 | No moat | No price data | |
| 380 | Vivani Medical, Inc. | VANI | $100.9M | 24 | No moat | No price data | |
| 381 | ACCURAY INCORPORATED | ARAY | $29.2M | 24 | No moat | No price data | |
| 382 | NeuroOne Medical Technologies Corporation | NMTC | $117.0M | 24 | No moat | No price data | |
| 383 | PASITHEA THERAPEUTICS CORP. | KTTA | $10.4M | 24 | No moat | No price data | |
| 384 | Pacific Biosciences of California, Inc. | PACB | $434.8M | 23 | No moat | No price data | |
| 385 | CITIUS PHARMACEUTICALS, INC. | CTXR | $9.0M | 23 | No moat | No price data | |
| 386 | Celularity Inc. | CELU | $22.5M | 23 | No moat | No price data | |
| 387 | CHARLIE’S HOLDINGS, INC. | CHUC | $55.5M | 23 | No moat | No price data | |
| 388 | InspireMD, Inc. | NSPR | $30.5M | 23 | No moat | 99% below value | |
| 389 | BROOKDALE SENIOR LIVING INC. | BKD | $3.6B | 23 | No moat | No price data | |
| 390 | ALPHA TEKNOVA, INC. | TKNO | $290.3M | 23 | No moat | No price data | |
| 391 | EASTMAN KODAK CO | KODK | $747.1M | 22 | No moat | 98% above value | |
| 392 | ClearSign Technologies Corp | CLIR | $18.8M | 22 | No moat | No price data | |
| 393 | Hyperfine, Inc. | HYPR | $76.1M | 22 | No moat | No price data | |
| 394 | NEXTNAV INC. | NN | $1.8B | 22 | No moat | No price data | |
| 395 | DarioHealth Corp. | DRIO | $47.1M | 22 | No moat | No price data | |
| 396 | CATHETER PRECISION, INC. | VTAK | $979901 | 21 | No moat | No price data | |
| 397 | Lucid Diagnostics Inc. | LUCD | $124.6M | 21 | No moat | No price data | |
| 398 | IGC PHARMA, INC. | IGC | $21.0M | 21 | No moat | No price data | |
| 399 | DOCGO INC. | DCGO | $64.2M | 21 | No moat | 76% below value | |
| 400 | ProPhase Labs, Inc. | PRPH | $594473 | 20 | No moat | No price data | |
| 401 | Tilray Brands, Inc. | TLRY | $4.6B | 20 | No moat | No price data | |
| 402 | Ernexa Therapeutics Inc. | ERNA | $50.4M | 20 | No moat | No price data | |
| 403 | ROCKWELL MEDICAL, INC. | RMTI | $241.4M | 20 | No moat | No price data | |
| 404 | CARDIFF ONCOLOGY, INC. | CRDF | $60.1M | 20 | No moat | No price data | |
| 405 | TALPHERA, INC. | TLPH | $65.4M | 20 | No moat | No price data | |
| 406 | NUTRIBAND INC. | NTRB | $37.8M | 20 | No moat | No price data | |
| 407 | SS INNOVATIONS INTERNATIONAL, INC. | SSII | $720.4M | 20 | No moat | No price data | |
| 408 | BioNexus Gene Lab Corp. | BGLC | $4.0M | 20 | No moat | No price data | |
| 409 | STRATA CRITICAL MEDICAL, INC. | SRTA | $448.0M | 20 | No moat | No price data | |
| 410 | SYNTEC OPTICS HOLDINGS, INC. | OPTX | $276.5M | 20 | No moat | 2935% above value | |
| 411 | AdaptHealth Corp. | AHCO | $1.5B | 20 | No moat | 93% above value | |
| 412 | Frequency Electronics, Inc. | FEIM | $650.4M | 19 | No moat | No price data | |
| 413 | Sonendo, Inc. | SONX | $350411 | 19 | No moat | No price data | |
| 414 | RadNet, Inc. | RDNT | $4.6B | 19 | No moat | 13513% above value | |
| 415 | Panacea Life Sciences Holdings, Inc. | PLSH | $1.3M | 19 | No moat | No price data | |
| 416 | CRONOS GROUP INC. | CRON | $1.1B | 19 | No moat | No price data | |
| 417 | ASCEND WELLNESS HOLDINGS, INC. | AAWH | $91.0M | 18 | No moat | No price data | |
| 418 | BIOMERICA, INC. | BMRA | $4.1M | 18 | No moat | No price data | |
| 419 | Harvard Apparatus Regenerative Technology, Inc. | HRGN | $18.5M | 18 | No moat | No price data | |
| 420 | AMERICAN SHARED HOSPITAL SERVICES | AMS | $9.3M | 17 | No moat | 62% below value | |
| 421 | HCW Biologics Inc. | HCWB | $26.9M | 17 | No moat | No price data | |
| 422 | BEYOND AIR, INC. | XAIR | $65.8M | 16 | No moat | No price data | |
| 423 | Butterfly Network, Inc. | BFLY | $1.6B | 16 | No moat | No price data | |
| 424 | FOCUS UNIVERSAL INC. | FCUV | $2.5M | 16 | No moat | No price data | |
| 425 | RECURSION PHARMACEUTICALS, INC. | RXRX | $1.6B | 16 | No moat | No price data | |
| 426 | SENSEONICS HOLDINGS, INC. | SENS | $210.9M | 16 | No moat | No price data | |
| 427 | Pulse Biosciences, Inc. | PLSE | $1.9B | 16 | No moat | No price data | |
| 428 | LIFECORE BIOMEDICAL, INC. | LFCR | $173.3M | 15 | No moat | No price data | |
| 429 | Personalis, Inc. | PSNL | $1.6B | 15 | No moat | No price data | |
| 430 | SYPRIS SOLUTIONS, INC. | SYPR | — | 14 | No moat | No price data | |
| 431 | POSITRON CORPORATION | POSC | $54.1M | 14 | No moat | No price data | |
| 432 | CANNAPHARMARX, INC. | CPMD | $1.2M | 14 | No moat | No price data | |
| 433 | CHINA PHARMA HOLDINGS, INC. | CPHI | $16.3M | 14 | No moat | No price data | |
| 434 | NexGel, Inc. | NXGL | $3.9M | 14 | No moat | No price data | |
| 435 | SERA PROGNOSTICS, INC. | SERA | $97.7M | 14 | No moat | No price data | |
| 436 | RAFAEL HOLDINGS, INC. | RFL | $27.7M | 14 | No moat | No price data | |
| 437 | Aditxt, Inc. | ADTX | $1029 | 14 | No moat | No price data | |
| 438 | AUTOLUS THERAPEUTICS PLC | AUTL | $383.2M | 14 | No moat | No price data | |
| 439 | PREMIER AIR CHARTER HOLDINGS INC. | PREM | $15.4M | 13 | No moat | No price data | |
| 440 | Outset Medical, Inc. | OM | $76.3M | 10 | No moat | No price data |